Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03343535 · ClinicalTrials.gov registry record · NA
OCS Lung System EXPAND II Trial
A NA study, sponsored by TransMedics.
- Terminated
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT03343535 is a NA study that was terminated before completion, run by TransMedics. The registered enrollment target is 46 participants.
The verdict
NCT03343535, a NA study, was terminated before completion, sponsored by TransMedics.
- TERMINATED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
To evaluate the safety and effectiveness of the OCS™ Lung System to recruit, preserve and assess non-ideal donor lungs that may not meet current standard donor lung acceptance criteria for transplantation.
Interventions
- DEVICE OCS Lung Preservation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2018-03-12 |
| Est. Completion | 2022-07-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03343535
The ClinicalTrials.gov registry entry for NCT03343535 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TransMedics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which OCS Lung Preservation is the first listed.
NCT03343535 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03343535 about?
NCT03343535 is a clinical study titled "OCS Lung System EXPAND II Trial". To evaluate the safety and effectiveness of the OCS™ Lung System to recruit, preserve and assess non-ideal donor lungs that may not meet current standard donor lung acceptance criteria for transplantation.
What is the current status of trial NCT03343535?
This trial is currently terminated. It is a NA study. The enrollment target is 46 participants. The study started on 2018-03-12. Estimated completion is 2022-07-06.
What interventions are being tested in trial NCT03343535?
The interventions under investigation include: OCS Lung Preservation (DEVICE).
Who is sponsoring clinical trial NCT03343535?
This trial is sponsored by TransMedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.